Gwen Nichols, Chief Medical Officer at Blood Cancer United, shared on LinkedIn:
“Thank you Blood Cancer United advocates! California voters have approved Proposition 38, making a significant investment in the future of immunology research. I’m proud that Blood Cancer United joined a broad coalition of physicians, nurses, researchers, community organizations, and others in support of the measure.
Immunotherapies are already transforming lives, and this investment will help accelerate the discoveries that bring new treatments, like CAR-T, and hope to patients facing blood cancer and other serious diseases. This investment, combined with the separately passed California Science and Health Research Bond, means billions of new dollars for science and technology to spur new breakthroughs that improve patients’ quality of life.
We look forward to working with members of the state legislature and partners to ensure these funds are allocated transparently and in ways that deliver the greatest benefit to patients.
Thank you to every patient, researcher, healthcare professional, advocate, and supporter who made this victory possible – and a special thank you to volunteer advocates Andrew Dale, Laurie Adami, and Bhavika Taunk for sharing your impactful stories.
Together, you’ve helped keep lifesaving medical research moving forward and brought us closer to more treatments, more cures, and more hope.”
You can also read: Most Oral Blood Cancer Prescriptions Face Insurance Rejection or Cost Barriers, US Study Finds
